Rahul was born in India. After predoctoral research on HIV, Rahul did his Ph.D. in Biotechnology at North Maharashtra University, India. With prior experience on host-virus interaction his focus is to study the in-vivo aspects of coronavirus infection. In the spare time Rahul likes to travel the world and spend time with his family.
Research Area: COVID-19 (SARS COVI-2)
Schulze-Gahmen
Ursula received her P hD in Biochemistry from the University of Heidelberg in Germany and expanded into structural biology during her postdoc years at the Scripps Research Institutes in La Jolla, CA and at UC Berkeley. At Gladstone she is studying viral protein-host interactions including viral proteins from HIV, SARS-Cov-2, and enterovirus. In her free time she likes gardening, traveling, and spending time with her family.
Khalid
I am fun-loving guy who does research on viral & host protein-protein interactions. In spare time I do blogging, Karate, Cooking, Gaming(PC), Soccer/PingPong and falling from the scooter regularly!
Taha
Taha trained in clinical pharmacy and medicinal chemistry at the University of Illinois at Chicago and developed an interest in virology after completing a fellowship at the CDC. In the Ott lab, he is interested in establishing an HBV infection system to study the molecular mechanisms and viral-host interactions governing disease persistence. In his free time, Taha enjoys spending time with his family, exploring national parks, and playing chess and soccer.
Ott
Institute of Virology
Senior Vice President, Gladstone Institutes
Professor of Medicine, UCSF
Melanie Ott earned her MD degree from University of Frankfurt in Germany and a PhD from the Picower Graduate School of Molecular Medicine in New York. In 1998, she started her own research group at the German Cancer Research Center in Heidelberg, Germany, in the department headed by tumor virologist and Nobel laureate Harald zur Hausen, studying HIV pathogenesis and a new emerging pathogen at the time, hepatitis C virus (HCV).
In 2002, she moved her lab to the Gladstone Institutes, where she continued her work on HIV and HCV, and expanded her research into the host-virus interface in diseases such as Zika, influenza and SARS-CoV-2. She has focused much of her work on the role of reversible protein acetylation in HIV transcription (especially the viral Tat protein), and identifying new molecular targets for treatments and cure, new diagnostics and the potential for pan-viral therapeutics.
Melanie is the Director of the Gladstone Institute of Virology Institute and Senior Vice President of the Gladstone Institutes, and a professor of medicine at University of California – San Francisco. She is a recipient of NIH MERIT and DP1 Avantgarde Awards, an elected member of the Association of American Physicians and a Fellow of the American Academy of Microbiology.